Cheng-Kai Kao to Cardiovascular Diseases
This is a "connection" page, showing publications Cheng-Kai Kao has written about Cardiovascular Diseases.
Connection Strength
0.082
-
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy. J Am Heart Assoc. 2017 Jul 11; 6(7).
Score: 0.082